News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Key Takeaways from the 468th CIBRC Meeting: Multiple Agrochemical Approvals Under Section 9(3) for Syngenta, Sumitomo, UPL, Atul, Rallis & Others

    Patented New ISO Name Approved – January 2026: Pendiclofenate, a new phenoxyacetic acid herbicide derivative compound from Corteva Agriscience

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Janssen Pharma’s Byannli (PP6M) receives European approval for Maintenance Treatment of Schizophrenia in Adults.

    adminNovember 25, 202102.9k views

    KEYPOINTS: Janssen has won approval from the European Commission for Byannli, a six-month formulation of Paliperidone Palmitate, two months after receiving a…

    Read more

    Rotam Expands Into New Markets with JOYA Herbicide Featuring Flumioxazin 51%.

    adminNovember 25, 202103.1k views

    SUMMARY: Rotam, a global leader in superior crop protection products, announces the launch of JOYA™, a versatile professional herbicide featuring the active…

    Read more

    Takeda’s LIVTENCITY (Maribavir) Approved by U.S. FDA as the First and Only Treatment of Post-Transplant Cytomegalovirus (CMV), that is Resistant to other Antiviral Drugs.

    adminNovember 25, 202103.9k views

    SYNOPSIS: Takeda announced that U.S. FDA Approved LIVTENCITY (Maribavir) as the First and Only Treatment for People Ages 12 or older and…

    Read more

    The Agrochemical Market in India: Prospects

    adminNovember 25, 202102.2k views

    Agrochemicals or agrichemicals is a contraction of agricultural chemical. It is a chemical product that is used in agriculture to increase the…

    Read more

    BioMarin`s VOXZOGO (Vosoritide) becomes the First U.S.FDA-approved Drug Therapy for Dwarfism.

    adminNovember 23, 202102.8k views

    Synopsis: BioMarin Pharmaceutical announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VOXZOGO™ (Vosoritide) for Injection, indicated…

    Read more

    Pfizer’s XELJANZ® (Tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis

    adminNovember 22, 202102.7k views

    Abstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor  XELJANZ® (Tofacitinib) 5 mg twice daily for the treatment…

    Read more

    US FDA Grants Orphan Drug Designation to Gracell’s FasTCAR-enabled BCMA/CD19 dual-targeting CAR-T cell therapy, GC012F to Treat Multiple Myeloma.

    adminNovember 22, 202102.3k views

    Synopsis: The FDA granted orphan drug designation to GC012F, a novel chimeric antigen receptor T-cell therapy for the treatment of relapsed or…

    Read more

    The US drug major Eli Lilly files patent litigation against 20 Indian companies on Baricitinib.

    adminNovember 21, 202103k views

    Highlights: The US drug major Eli Lilly has filed a patent infringement litigation at the Delhi High Court against several Indian pharmaceutical…

    Read more

    GSK and Vir Biotechnology announce United States Government Agreements to Purchase Sotrovimab, a COVID-19 Treatment.

    adminNovember 20, 202101.8k views

    SYNOPSIS US government contracts for approximately $1 billion (USD) are now in place to purchase Sotrovimab, further expanding access nationwide Sotrovimab, an…

    Read more

    NATCO Pharma launches Tipanat (Trifluridine + Tipiracil) Tablets in India, for the Treatment of Advanced Colorectal and Gastric Cancer.

    adminNovember 20, 202103.7k views

    KEYPOINTS: Natco Pharma Limited has launched a novel fixed-dose combination of Trifluridine + Tipiracil for the first-time in India under the brand…

    Read more

    Posts navigation

    1 … 81 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top